MPDD Doctor review 2/21/13 via email Dear EPGL

New Post Public Reply Private Reply Replies (0) Message Board
steelerfan7

MPDD Doctor review

2/21/13

via email

Dear EPGL Staff,

As you know I have had the opportunity to purchase and implement the Muscle

Pain Detection Device into my pain management practice. I just wanted to give

you some feedback as to my experience with the device, which up to this point

has been quite encouraging. The scope of my practice has allowed me to

frequently use the device. I see a wide variety of painful conditions, many of

which are challenging to treat. Needless to say, a proper diagnosis is essential

for good care. My practice is referral based and include painful conditions

involving the neck, shoulders, chest, thoracic and lumbar back, gluteal and hip

region, knee and leg pain. I often see patients that have tried and failed many

other modalities.

Up to this point I have to say that my experience with the Muscle Pain Detection

Device has been very positive. It is easy to use and tolerated very well by the

patients. I have had zero patient complaints and in fact they are quite enthused

to try a diagnostic tool that offers some insight as to the source of their pain

problem. It is encouraging to them when we are able to specifically identify the

muscle region causing their pain. They are then very responsive to treatment of

the painful muscle via injections and a structured exercise regimen.

It's interesting that I will often get a referral to treat a patient for a particular

problem (for example a cervical or lumbar epidural injection) and then after

using the MPDD find that the patient either has a muscle problem causing the

pain or has muscle pain in addition to the original problem. Seeing this over

and over again has basically prompted me to used the MPDD on almost every

patient that is scheduled for an injection. I'm hoping to incorporate the device

more often even on my medically managed patients also. My goal is to

properly diagnose and treat these patients with the least amount of

intervention and medication.

Without being too long winded, I just have to tell you about a few of my

experiences with the device. It's no surprise that the device can confirm a

palpated trigger point quite easily. However, I find it interesting that the device

identifies painful muscle regions that are not palpated by traditional exam. For

example, I had an elderly gentleman who has had chronic neck pain for

years. He has had surgery, facet joint injections, medications and physical

therapy but just has not had any relief of the pain. He pointed to the cervical 2

paraspinous region as the source of the discomfort. However, when I used the

MPDD I was able to identify painful muscles 3cm lateral to where he was

pointing. I injected this region and started him on appropriate home

exercises. He is now starting to notice relief!!

I had another patient with low back pain who was scheduled to see me for

injections into the joints of the back. She had had good relief with these

injectionsin the past. However she was frustrated that she had developed right

inguinal (groin) pain and had been dealing with it for months. I was unable to

palpate any trigger points. I then used the MPDD on her back and gluteal

region and identified a tender muscle over a gluteal multifidi muscle. As I was

stimulating the muscle the patient responded with "That's it!" I injected the

muscle and within five minutes her inguinal pain was gone. Needless to say she

was very happy (and so was I).

I had another patient that was referred to me for hip joint injections secondary

to arthritis of the right hip joint. I injected the joint twice with no relief. I then

used the MPDD and identified tender muscles over the gluteus minimus,

gluteus medius, and piriformis region. I injected these muscles and it was like

flipping a switch, her pain improved 90%. This is something she can easily

repeat with little to no risk. She was otherwise facing surgery.

Another gentleman I was treating with gluteal pain actually had no pain when I

palpated manually and tested over the gluteal musculature with the

MPDD. However, when I tested the muscles up higher in the lumbar back with

the MPDD (Iliocostalis muscle), this reproduced hi pain! I injected the muscle

and he had relief of the gluteal pain. This shows how relevant referred muscle

pain is. With referred pain it is often difficult to identify the actual source as it is

away from the painful site and in and of itself may produce minimal or no pain

during day to day life. As you can see this certainly adds to the quality of care

and is satisfying to both patient and physician.

I can go on and on with cases where the MPDD has helped me identify muscle

pain sources but I won't bore you. Let's just say that I'm using it on a daily basis

on well over 50% of my patients.

So in my experience I am consistently finding that the painful areas that a

patient points to as being the source of the pain are often different then where

the MPDD detects the discomfort. This is important, as it is frustrating to

patient and physician when traditional treatments offers no relief. The MPDD

allows us to change that in many cases, at least in my experience. I usually do 3

not inject muscles that the MPDD doesn't detect as painful even if the patients

states it hurts in a certain area. This prohibits needless, ineffective injections.

It would be interesting to hear from the other physicians using the device. I

think shared experiences can help identify consistent pain patterns which can

the be better treated. It would be good to develop clinical "Pearls" that would

assist physicians as they start to use the device. There is a learning curve and I

recommend using a good anatomy text (I use the Netter Series and the Visible

Body computer application) to really brush up on the anatomy as it is important

obviously. It is also a help to have knowledge of the traditional trigger point

patterns (as developed by Dr Travell). I have purchased the wall charts and they

have helped me in learning the wide variety of trigger point

patterns. Knowledge is power!

As far as downfalls of the MPDD are concerned there are few. When I started

using the device it took some practice to identify where to start and adjusting

the power but that quickly became a non issue with experience. It does take

some time to use the device but I'm finding that again with experience I have

cut that down dramatically and it is essentially also now a non issue. I find that I

need to change the battery a few times a week but this is obviously not a big

deal. Also, I have purchased a large lot of grounding pads and conduction gel

so I don't run out. I have found a couple of good distributors that are cost

effective and can relay that information if it would help you. Considering that I

use the device daily on multiple patients even the up front cost of the device

has been a moot point as it has probably paid for itself within the first month or

two of consistent use.

If you like I can periodically update you on my experience with the

device. Again, I would also like to hear how other physicians and health care

providers are doing with it as I am always eager to learn new things that can

improve patient care.

Sincerely,

Kenneth J Wenz, MD

Coastal Interventional Pain Associates

Myrtle Beach, SC

EP Global Communications Inc. (EPGL) Stock Research Links

EPGL Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

FJBio Boosts Antibody Discovery with Sapio AI

Updated Category News Views 0

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Anecdotes by Artists Brings Raw Scent Stories to Sephora

Updated Category News Views 0

When Maesa pulls back the curtain, they don't just crack it open—they fling it aside with flair. That's precisely what they're doing with their latest venture, Anecdotes by Artists, a fragrance brand that's taking its first bow exclusively at Sephora. It's not your average perfume launch; it's about the stories behind the scents and the artists who craft them. Unveiling...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 0

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading
Cracking the Code of America's Delivery Addiction

Updated Category News Views 2

America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...

Continue Reading
The Chemical Industry and EPA: A Broken System?

Updated Category News Views 1

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Continue Reading
Compass Unveiled: Power Revolution in Private Equity

Updated Category News Views 2

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading

Top 5 Most Recently Viewed Articles

Jacobio Pharma Allies with AstraZeneca to Combat KRAS Mutations

Updated Category News Views 190

Jacobio Pharma's Strategic Alliance with AstraZeneca Jacobio Pharma has recently entered a significant agreement with AstraZeneca aimed at developing the Pan-KRAS inhibitor, JAB-23E73. This collaboration places Jacobio on a global stage, as AstraZeneca will take the reins on development and commercialization of JAB-23E73 outside of China. Financial and Development Terms...

Continue Reading
Celebrating 25 Years of Excellence in Workplace Health

Updated Category News Views 154

Axiom Medical Celebrates 25 Years of Workplace Safety Axiom Medical, a leader in occupational health and workplace injury case management solutions, recently marked a significant milestone, celebrating 25 years of commitment to ensuring safer workplaces. This celebration took place at its annual Client Summit, held in the vibrant Houston area, where leaders from health,...

Continue Reading
Microsoft’s Upcoming Call of Duty Movie: Box Office Potential

Updated Category News Views 203

Microsoft's Latest Cinematic Venture Microsoft Corp (NASDAQ: MSFT) has made headlines recently with its successful collaboration on the 'Minecraft' movie, a significant hit at the box office. This triumph has opened doors for the tech giant, which has now established a partnership with Paramount Skydance to bring gaming franchises to the big screen. What’s on the...

Continue Reading
Jessica Andrews Joins Brighton Jones to Elevate Family Office Services

Updated Category News Views 214

Welcoming Jessica Andrews to Brighton Jones Brighton Jones, a prominent wealth management firm, is excited to announce that Jessica Andrews has been appointed as the General Manager of Lenora Family Office and Multi-Family Office. Her selection represents a strategic enhancement to the firm's commitment to providing high-quality service to ultra-high-net-worth families....

Continue Reading
Grab Partners with AWS for Enhanced Technology Solutions

Updated Category News Views 481

Grab Chooses AWS to Propel Technological Advancements At the recent AWS re:Invent event, Grab, known as Southeast Asia’s leading superapp (NASDAQ: GRAB), made a significant move by announcing its partnership with Amazon Web Services, Inc. (AWS), a subsidiary of Amazon.com, Inc. (NASDAQ: AMZN). This collaboration marks a pivotal step as Grab aims to enhance its...

Continue Reading